Daiichi Sankyo

Activities: Packaging Research & Development Pharmaceutical

Trending Articles

  1. Olon strengthens market position with acquisitions ahead of CPHI Milan Two new acquisitions expand Olon’s service offerings and production capacity
  2. Improving the sustainability of pharmaceutical freeze drying with ECO Mode Freeze dryers are typically associated with high levels of energy consumption; to counteract this issue, GEA Pharma & Healthcare has introduced the LYOVAC ECO Mode, which...
  3. Microbial identification of drug contamination: MALDI-TOF MS as an efficient alternative This article describes the growing need for fast and accurate microbial detection in the pharmaceutical manufacturing supply chain
  4. Almac Group announces £11m investment to expand global analytical services The Almac Group has announced an £11m investment and the creation of more than 100 new jobs to expand its global analytical services capabilities
  5. Neopac unveils new Polyfoil mono-material barrier mini tubes Small-size tubes enhance protection and versatility for pharmaceutical and oral care applications

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Regulatory

AstraZeneca & Daiichi Sankyo's Enhertu bags another approval for gastric cancer applications

The HER2-targeting ADC has received conditional approval owing to the results of the DESTINY-Gastric06 Phase II trial

Therapeutic: datopotamab deruxtecan for breast cancer

Of all the various forms of breast cancer, triple negative is the most aggressive subtype
Research & Development

AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study

Results for the TROP2-directed antibody drug conjugate demonstrated statistically significant improvement in progression-free survival vs. standard chemotherapy
Drug Delivery

ProLynx collaborates with Daiichi Sankyo on drug delivery

The collaboration will evaluate the utility of the releasable linker technology in half-life extension of small-molecule drugs after intravitreal injection
Finance

Heptares Therapeutics enters agreement with Daichi Sankyo

The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Pharmaceutical

Amgen and Daiichi Sankyo to commercialise biosimilars in Japan

The exclusive agreement includes nine biosimilars in late-stage development
Drug Delivery

Nitto Denko enters drug delivery partnership with Daiichi Sankyo

To accelerate the commercialisation of Nitto’s PassPort transdermal drug delivery technology
Subscribe now